Yeast a mating factor structure-activity relationship derived from genetically selected peptide agonists and antagonists of Ste2p

Yeast a mating factor structure-activity relationship derived from genetically selected peptide agonists and antagonists of Ste2p

Manfredi, J.P.; Klein, C.; Herrero, J.J.

Molecular and Cellular Biology 16: 00-9

1996

ISSN/ISBN: 0270-7306

(PDF emailed within 1 workday: $29.90)

Accession: 018212993

Download citation: RIS BibTeX Text

Related references

Yeast alpha mating factor structure-activity relationship derived from genetically selected peptide agonists and antagonists of Ste2p. Molecular and Cellular Biology 16(9): 4700-4709, 1996

Nmr studies on the conformations of tri deca peptide alpha mating factor from yeast saccharomyces cerevisiae and analog peptides in aqueous solution conformation activity relationship. European Journal of Biochemistry 140(1): 163-172, 1984

Structure-activity relationship of synthetic and semisynthetic opioid agonists and antagonists. Acta Pharmaceutica Hungarica 63(6): 335-349, 1993

Structure of genes encoding precursors of the yeast peptide mating pheromone alpha factor. Gething, M -J (Ed ) Current Communications in Molecular Biology Protein Transport And Secretion; Meeting, Cold Spring Harbor, N Y , Usa, Nov 1984 X+215p Cold Spring Harbor Laboratory: Cold Spring Harbor, N Y , Usa Illus Paper 103-108, 1985

Investigation into the structure-activity relationship of novel concentration dependent, dual action T-type calcium channel agonists/antagonists. Bioorganic and Medicinal Chemistry 13(11): 3821-3839, 2005

The structure-activity relationship of the series of non-peptide small antagonists for p56lck SH2 domain. Bioorganic and Medicinal Chemistry 15(11): 3938-3950, 2007

Structure-activity relationship of vasoactive intestinal peptide (VIP): potent agonists and potential clinical applications. Naunyn-Schmiedeberg's Archives of Pharmacology 377(4-6): 579-590, 2008

Discovery and structure-activity relationship of the first non-peptide competitive human glucagon receptor antagonists. Journal of Medicinal Chemistry 41(26): 5150-5157, 1998

New non-peptide angiotensin II receptor antagonists. 2: structure - activity relationship of a series of annelated 2(1H)-pyridinones. Bioorganic and Medicinal Chemistry Letters 4(1): 127-132, 1994

Bicyclic peptide antagonists derived from genetically encoded combinatorial libraries. Chimia 65(9): 677-679, 2011

Computational structure-activity relationship analysis of small-molecule agonists for human formyl peptide receptors. European Journal of Medicinal Chemistry 45(11): 5406-5419, 2010

Purification and its structure activity relationship of mating factor of Saccharomyces cerevisiae. Proceedings 53 (2) 67-70, 1977

Structure-activity relationship of 2-amino-3-heteroaryl-quinoxalines as potent, non-peptide interleukine-8-receptor antagonists. Abstracts of Papers American Chemical Society 220(Part 1): MEDI 144, 2000

A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists. British Journal of Pharmacology 73(3): 703-719, 1981

Himbacine derived thrombin receptor (PAR-1) antagonists: structure-activity relationship of the lactone ring. Bioorganic and Medicinal Chemistry Letters 16(18): 4969-4972, 2006

< Previous

∧ Chapter

Next >

© 2022 EurekaMag OÜ, Sakala 7-2, 10141 Tallinn, Estonia, Tel: +372 69 91692
Registry code: , Legal Entity Identifier (LEI): 984500A2C1AE68HDA873
Privacy · Disclaimer · Terms · Contact · 浙ICP备10204677号-1